Latest filing published 07 Oct 2022 for Ocugen, Inc., €8,412.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -84.0%Entry US$12,993.75 · Close at T+365 US$2,081.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ramesh Kumar: trading record in brief
Ramesh Kumar is a declared insider at 2 companies (board member); the most frequent names are Traws Pharma, Inc. and Ocugen, Inc. The record holds 38 filings, for trades running from 7 February 2013 to 6 October 2022.
The open-market side counts 3 purchases for €131k alongside 12 sales for €1.2M. Taken together, the sales exceed the purchases by €1.1M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant and 13 option exercises. Since January 2022: no purchases and 4 sales on the market.
In size, the median ticket on the buying side is €46k.
The latest filing, published on 7 October 2022, reports an open-market sale of €8,412 in Ocugen, Inc. The last purchase on record was published on 28 April 2017, which is 3,482 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ramesh Kumar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,500 shares@ US$1.833.8% of flowCommon StockSEC:0001062993-22-020658:1
- 4,500 shares@ US$0.5112.0% of flowCommon StockSEC:0001062993-22-020658:0
- 7,500 shares@ US$2.578.5% of flowCommon StockSEC:0001062993-22-016559:1
- 7,500 shares@ US$0.5119.3% of flowCommon StockSEC:0001062993-22-016559:0
- 7,500 shares@ US$2.838.8% of flowCommon StockSEC:0001062993-22-010494:1
- 7,500 shares@ US$0.5118.1% of flowCommon StockSEC:0001062993-22-010494:0
- 7,500 shares@ US$4.0712.0% of flowCommon StockSEC:0001062993-22-001294:1
- 7,500 shares@ US$0.5117.1% of flowCommon StockSEC:0001062993-22-001294:0
- 7,500 shares@ US$8.1335.2% of flowCommon StockSEC:0001879785-21-000009:1
- 7,500 shares@ US$0.5116.8% of flowCommon StockSEC:0001879785-21-000009:0
- 7,500 shares@ US$6.4027.3% of flowCommon StockSEC:0001192482-21-000636:1
- 7,500 shares@ US$0.5116.6% of flowCommon StockSEC:0001192482-21-000636:0
- 7,500 shares@ US$0.512.1% of flowCommon StockSEC:0001192482-21-000346:0
- 7,500 shares@ US$5.3322.3% of flowCommon StockSEC:0001192482-21-000346:1
- 23,810 shares@ US$2.1019.6% of flowCommon StockSEC:0001179110-17-006246:0Canonical exit: 25 Jul 2017 (T+90)
- 50,765 shares@ US$4.1080.4% of flowCommon StockSEC:0001179110-16-028544:0
- 13,543 shares@ US$6.00Common StockSEC:0001179110-14-002539:0
- 13,543 shares@ US$15.02Common StockSEC:0001179110-14-002539:1
- 20,000 shares@ US$6.00Common StockSEC:0001179110-14-002539:2
- 20,000 shares@ US$15.11Common StockSEC:0001179110-14-002539:3
- 5,256 shares@ US$2.67Common StockSEC:0001179110-14-001745:0
- 14,744 shares@ US$6.00Common StockSEC:0001179110-14-001745:1
- 20,000 shares@ US$15.05Common StockSEC:0001179110-14-001745:2
- 20,000 shares@ US$6.00Common StockSEC:0001179110-14-001745:3
- 20,000 shares@ US$15.03Common StockSEC:0001179110-14-001745:4
25 of 37 declarations
